CN1223870A - Psoriasis capsule - Google Patents
Psoriasis capsule Download PDFInfo
- Publication number
- CN1223870A CN1223870A CN98100151A CN98100151A CN1223870A CN 1223870 A CN1223870 A CN 1223870A CN 98100151 A CN98100151 A CN 98100151A CN 98100151 A CN98100151 A CN 98100151A CN 1223870 A CN1223870 A CN 1223870A
- Authority
- CN
- China
- Prior art keywords
- radix
- prescription
- fructus
- medicine
- margarita
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A medical capsule for treating psoriasis is prepared based on one of four prescriptions. The prescription No.1 includes 6 Chinese-medicinal materials such as ox gallstone, pearl, dittany bark, etc. The prescription No.2 includes 7 Chinese-medicinal materials such as Saussurea involucrata, pearl, gypsum, etc. The prescription No.3 includes 11 Chinese-medicinal materials such as raw Dragon's bone, oyster shell, natural indigo, prunella spike, etc. The prescription No.4 includes 21 Chinese-medicinal materials such as rehmannia root, liquorice root, astragalus root, Chinese angelica root, etc. Its advantages are high cure rate and no recurrence.
Description
The present invention relates to the psoriatic psoriasis capsule of a kind of treatment, belong to the dermopathic Chinese medicinal capsule of treatment.
Psoriasis is a kind of common dermatosis with chronic, easy recurrence of characteristic skin lesion, and at present, of a great variety for the Therapeutic Method of this disease, it is low that many Therapeutic Method all have cure rate, easily deficiency such as recurrence.Delivered Gu Chuan, the river show employing bitter guarantor of leakage material and polyvalent unsaturated fatty acid according to seven kinds of dermatosis magazines of Japanese 90-95 and treated psoriatic six pieces of reports, its cure rate is zero.Reports such as Germany Hermeickvon and the RPmwKoTH of Russia have only been reported effective percentage and have been respectively 98% and 95%.Domestic report is with traditional Chinese medical herbal treatment curative effect the best, and cure rate is at 20-67%, and is only applicable to homeliness type.The method that adopts Chinese and western medicine to combine does not in addition have breakthrough curative effect yet.The Chinese medicine of employing photochemical therapy is arranged at present, optical photon therapy, blood magnetotherapy, autohemotherapy, catgut embedding therapy, dialysis therapy etc. again.Wherein photochemical therapy, blood magnetotherapy curative effect the best, but there is unsurmountable shortcoming, selection, irradiation time as its wavelength of photochemical therapy are subjected to all multifactor influences as season, sex, age, position, the colour of skin, nutrition, situation, endocrine factors, disease situation, dosage is difficult for grasping, and improper use causes adverse consequences on the contrary.Buy expensive blood magnetizing machine but the blood magnetotherapy is essential, medical expense costliness, and patient Duo Yin blood vessel is in bad order, factor such as be in a bed economic state, the course of treatment that often can not finish defined.
The objective of the invention is to overcome many deficiencies of above-mentioned prior art and a kind of cure rate height is provided, short treating period, four kinds of capsules are taken continuously, and toxic and side effects is light, economical and practical psoriasis capsule.
The object of the present invention is achieved like this: it is made of four kinds of prescriptions, and its prescription and content are: prescription 1 is made up of six kinds of Chinese medicines, and the weight percent content of each medicine of distinguishing the flavor of is Calculus Bovis 1-5; Margarita 5-20, favus skin 6-30 insults tip flower 10-30; Radix Tripterygii Wilfordii 6-20, Flos Sophorae 9-20.Prescription 2 is made of eight kinds of Chinese medicines, and the weight percent content of each medicine of distinguishing the flavor of is Herba Saussureae Involueratae 10-20, Margarita 10-20, Gypsum Fibrosum 10-20, Zaocys 8-18, Fructus Aurantii 5-15, Indigo Naturalis 5-15, Radix Angelicae Dahuricae 5-15, Fructus Arctii 5-15.Prescription 3 is made of 11 kinds of Chinese medicines, and the weight percent content of each medicine of distinguishing the flavor of is Os Draconis 8-20, Concha Ostreae 7-20, Semen Cassiae 10-30 not, Indigo Naturalis 5-15, Spica Prunellae 8-20, Pericarpium Citri Reticulatae Viride 5-20, Fructus Aurantii 5-15, Radix Scrophulariae 10-30, Radix Stemonae 3-15, Margarita 8-20, Radix Rumicis silk 1-5.Prescription 4 is made of 22 kinds of Chinese medicines, and the weight percent content of each medicine of distinguishing the flavor of is Radix Rehmanniae 3-13, Radix Glycyrrhizae 2-5, Hemerocallis citrina Baroni 5-15, Radix Angelicae Sinensis 4-8, Olibanum 0.5-3, Myrrha 0.5-2, Rhizoma Chuanxiong 0.5-1.5, Carapax et Plastrum Testudinis 1-4, Colla Corii Asini 1-3, Fructus Aurantii 1.5-5, each 1-3 of two skins, Rhizoma Pinelliae 0.5-3, Radix Platycodonis 0.5-1.5, Radix Bupleuri 0.5-2.5, Os Draconis 3-9, Concha Ostreae 2-6, Massa Medicata Fermentata 1-5, Fructus Hordei Germinatus 5-15, Endothelium Corneum Gigeriae Galli 1-3, Fructus Gardeniae 0.5-1.5, Radix Panacis Quinquefolii 2-8, Cordyceps 1-3.Purpose of the present invention can also realize by following technical measures: the optimized percentage content of prescription 1 is Calculus Bovis 3.6, Margarita 18.2, and favus skin 16.3 is insulted the tip and is spent 27.3, Radix Tripterygii Wilfordii 16.4, Flos Sophorae 18.2.The optimized percentage content of described prescription 2 is Herba Saussureae Involueratae 15, Margarita 15, Gypsum Fibrosum 15, Zaocys 15, Fructus Aurantii 10, Indigo Naturalis 10, the Radix Angelicae Dahuricae 10, Fructus Arctii 10.The optimized percentage content that is described prescription 3 is Os Draconis 9.3, Concha Ostreae 9.3, and Semen Cassiae 15.4, Indigo Naturalis 9.3, Spica Prunellae 12.3, Pericarpium Citri Reticulatae Viride 9.3, Fructus Aurantii 6.2, Radix Scrophulariae 12.2, the Radix Stemonae 6.2, Margarita 9.3 Radix Rumicis silks 1.2.The optimized percentage content of described prescription 4 is the Radix Rehmanniae 10.3, Radix Glycyrrhizae 3.2, the Radix Astragali 13.9, Radix Angelicae Sinensis 7.7, Olibanum 1.9, Myrrha 1.9, Rhizoma Chuanxiong 1.3, Carapax et Plastrum Testudinis 3.9, Colla Corii Asini 2.6, Fructus Aurantii 3.2, two skins each 1.9, the Rhizoma Pinelliae 1.9, Radix Platycodonis 1.3, Radix Bupleuri 1.9, Os Draconis 7.7, Concha Ostreae 5.2, Massa Medicata Fermentata 3.2, Fructus Hordei Germinatus 13.9, Endothelium Corneum Gigeriae Galli 2.7, Fructus Gardeniae 1.3, Radix Panacis Quinquefolii 6.5, Cordyceps 2.6.Above-mentioned prescription is ground into respectively do not make capsule, the heavy 0.6g of every ball.
Compared to existing technology, the present invention has the following advantages:
1, cure rate height reaches 97%, adds basic healing, and cure rate can reach 100%.
2, short treating period is generally healing in 15-30 days.
3, toxic and side effects is slight, and hepatic and renal function is not had influence.
4, be applicable to all kinds, the psoriasis of each phase.
5, treatment back skin recovers normal fully.
6, pharmaceutical methods, instructions of taking is simple, is applicable to hospitals at different levels, and clinic uses.
7, price is cheap, and the medicine source is extensive, is easy to processing.
8, relapse rate is low, and medicine is reusable, and recurrence treatment again has identical curative effect.
Pharmacological action of the present invention.
The effect of the pharmacology of No. 1 medicine (prescription 1): have clearing away heat,cooling blood and removing toxin, activating blood circulation to dissipate blood stasis, blood enriching and dryness moistening, the effect of dispelling wind for relieving itching.
No. 2 medicines (prescription 2) compensate qi and blood, expelling wind and removing dampness, promoting blood circulation to remove obstruction in the collateral, removing scurf and relieving itching.
No. 3 medicines (prescription 3): clearing away heat-fire, detoxicatied spot-removing, parasite killing granulation promoting, the soft kidney of cloudy now YANG hyperactivity suppressing.
No. 4 medicines (prescription 4) wind-damp dispelling, strong muscle is mended bone water, QI invigorating YANG invigorating, eliminating stagnation.
The biological alkali and the terpenoid of 1-4 medicine have following pharmacological action:
1, can suppress antibody forms.Modern study confirms that lgA and lgE raise in psoriatic's serum, also have anti-lgG antibody simultaneously, and anti-cutin autoantibody is arranged in horny layer, so the 1-4 series Chinese medicine tissue injury that can suppress immunoreation and be caused.
2, patient CAnP/CGMP ratio is starkly lower than the normal person before the treatment, and CAMP descends, and can cause that epidermis cell has floating division growth too fast, thereby row causes that keratinization of epidermis is incomplete, treats the latter two ratios and recovers normal.
3, can suppress basal cell, thus the too fast Parakeratotic pathological process of horny layer that changed of prickle cell layer division growth.
4, microcirculation improvement, reduce blood viscosity and improve blood platelet disorders gathering and adhesion, evidence diseased region microcirculation changes and will disappear several months even 1 year ability recovery normally at skin lesion, the performance of aberrant angiogenesis bending is also arranged at skin lesions circumferece normal appearance skin, this illustrates that psoriatic generation development may be to occur corium blood capillary ANOMALOUS VARIATIONS earlier, the clinical skin lesion that can see then could occur, this just provides strong theoretical foundation for the activating blood circulation to dissipate blood stasis treatment psoriasis of Chinese medicine.
5, the 1-4 medical instrument has the antiinflammatory sterilization, and effects such as antiallergic are also played good effect undoubtedly to psoriasis.
Below in conjunction with embodiment in detail the present invention is described in detail.
The present invention is by the 1-4 medicine, and the 1-4 that both filled a prescription forms, and wherein No. 1 medicine is made up of Calculus Bovis, Margarita, favus skin, icepro tip flower, Radix Tripterygii Wilfordii, six kinds of Chinese medicines of Flos Sophorae, and its formulation Example is represented with following table 1:
Table 1
| The medicine name | Weight percent content | |||||||
| Calculus Bovis | 3.6 | ????1 | ???2 | ????5 | ????4 | ????4 | ????3 | ????5 |
| Margarita | 18.2 | ????19 | ????5 | ????20 | ????20 | ????18 | ????20 | ????10 |
| Favus skin | 16.3 | ????28 | ????30 | ????26 | ????6 | ????30 | ????24 | ????19 |
| Icepro tip flower | 27.3 | ????15 | ????30 | ????25 | ????30 | ????10 | ????29 | ????26 |
| Radix Tripterygii Wilfordii | 16.4 | ????17 | ????20 | ????6 | ????20 | ????19 | ????15 | ????20 |
| Flos Sophorae | 18.2 | ????20 | ????13 | ????18 | ????20 | ????19 | ????9 | ????20 |
No. 2 medicine is made up of Herba Saussureae Involueratae, Margarita, Gypsum Fibrosum, Zaocys, Fructus Aurantii, Indigo Naturalis, the Radix Angelicae Dahuricae, eight kinds of Chinese medicines of Fructus Arctii, and its formulation Example is represented with following table 2:
Table 2
| The medicine name | Weight percent content (%) | ||||
| Herba Saussureae Involueratae | 15 | ????10 | ????14 | ????20 | ?18 |
| Margarita | 15 | ????20 | ????18 | ????10 | ?14 |
| Gypsum Fibrosum | 15 | ????10 | ????20 | ????18 | ?17 |
| Zaocys | 15 | ????8 | ????18 | ????10 | ??9 |
| Fructus Aurantii | 10 | ????15 | ????5 | ????8 | ?11 |
| Indigo Naturalis | 10 | ????8 | ????15 | ????5 | ?13 |
| The Radix Angelicae Dahuricae | 10 | ????15 | ????5 | ????14 | ??9 |
| Fructus Arctii | 10 | ????14 | ????5 | ????15 | ??9 |
No. 3 medicines are not by Os Draconis, Concha Ostreae, Semen Cassiae, Indigo Naturalis Spica Prunellae, Pericarpium Citri Reticulatae Viride, Fructus Aurantii, Radix Scrophulariae, the Radix Stemonae, Margarita, 11 kinds of Chinese medicines of Radix Rumicis silk are formed, and its formulation Example is represented with following table 3:
Table 3
No. 4 medicine Radix Rehmanniae, Radix Glycyrrhizae, the Radix Astragali, Radix Angelicae Sinensis, Olibanum, Myrrha, Rhizoma Chuanxiong, Carapax et Plastrum Testudinis, Colla Corii Asini, Fructus Aurantii, two skin each, the Rhizoma Pinelliae, Radix Platycodonis, Radix Bupleuri, Os Draconis, Concha Ostreae, Massa Medicata Fermentata, Fructus Hordei Germinatus, Endothelium Corneum Gigeriae Galli, Fructus Gardeniae, Radix Panacis Quinquefolii, 22 kinds of Chinese medicines of Cordyceps form.Its formulation Example is represented with following table 4:
| The medicine name | Weight percent content (%) | ||||||||
| Os Draconis | 9.3 | ????20 | ????10 | ????12 | ????8 | ????9 | ????8 | ????8 | ????9 |
| Concha Ostreae | 9.3 | ????7 | ????10 | ????20 | ????7 | ????8 | ????7 | ????9 | ????7 |
| Semen Cassiae not | 15.4 | ????10 | ????30 | ????10 | ???13 | ????10 | ????10 | ????10 | ???10 |
| Indigo Naturalis | ?9.3 | ????15 | ????8 | ????10 | ????8 | ????8 | ????9 | ????8 | ???20 |
| Spica Prunellae | 12.3 | ????8 | ????8 | ????8 | ????10 | ????8 | ????10 | ????8 | ???20 |
| Pericarpium Citri Reticulatae Viride | ?9.3 | ????5 | ????5 | ????5 | ????7 | ????5 | ????6 | ????20 | ????5 |
| Fructus Aurantii | ?6.2 | ????5 | ????5 | ????5 | ????8 | ????5 | ????6 | ????15 | ????5 |
| Radix Scrophulariae | ?12.2 | ???10 | ????11 | ????10 | ????15 | ????20 | ????30 | ????10 | ???10 |
| The Radix Stemonae | ??6.2 | ????3 | ????4 | ????5 | ????3 | ????15 | ????3 | ????3 | ????4 |
| Margarita | ??9.3 | ???16 | ????8 | ????10 | ????20 | ????11 | ????8 | ????8 | ????8 |
| The Radix Rumicis silk | ??1.2 | ????1 | ????1 | ????5 | ????1 | ????1 | ????3 | ????1 | ????2 |
Table 4
| The medicine name | Weight percent content (%) | |||||||
| The Radix Rehmanniae | ???10.3 | ????5 | ????9 | ????3 | ????13 | ????13 | ????13 | ????12 |
| Radix Glycyrrhizae | ????3.2 | ????5 | ????4 | ????2 | ????5 | ????5 | ????5 | ????4 |
| The Radix Astragali | ???13.9 | ???15 | ???13 | ????15 | ????5 | ????15 | ????15 | ????14 |
| Radix Angelicae Sinensis | ????7.7 | ????8 | ????5 | ????8 | ????8 | ????4 | ????8 | ????8 |
| Olibanum | ????1.9 | ?0.5 | ????3 | ????2 | ????3 | ????3 | ????3 | ????3 |
| Myrrha | ????1.9 | ???2 | ?0.5 | ????2 | ????1 | ????2 | ????2 | ????2 |
| Rhizoma Chuanxiong | ????1.3 | ?0.5 | ?1.5 | ????1 | ??1.5 | ??1.5 | ????1 | ??1.5 |
| Carapax et Plastrum Testudinis | ????3.9 | ???3 | ???4 | ????4 | ????3 | ?1 | ?4 | ?4 |
| Colla Corii Asini | ????2.6 | ???2 | ???3 | ????1 | ????3 | ????3 | ????3 | ????3 |
| Fructus Aurantii | ????3.2 | ???5 | ?1.5 | ????5 | ????4 | ????5 | ????5 | ????5 |
| Two skins respectively | ????1.9 | ???1 | ???3 | ????3 | ??2.5 | ????3 | ????3 | ????3 |
| The Rhizoma Pinelliae | ????1.9 | ?0.5 | ???3 | ????3 | ??2.5 | ????3 | ????3 | ????3 |
| Radix Platycodonis | ????1.3 | ?0.5 | ?1.5 | ?1.5 | ??1 | ???1.5 | ???1.5 | ???1.5 |
| Radix Bupleuri | ????1.9 | ?2.5 | ????2 | ?2.5 | ??0.5 | ??2.5 | ????2 | ???2.5 |
| Os Draconis | ????7.7 | ????9 | ????8 | ????9 | ????8 | ????7 | ????5 | ????3 |
| Concha Ostreae | ????5.2 | ????6 | ????6 | ????6 | ????5 | ????6 | ????3 | ????2 |
| Massa Medicata Fermentata | ????3.2 | ????5 | ????5 | ????4 | ????5 | ????5 | ????1 | ????5 |
| Fructus Hordei Germinatus | ???13.9 | ??15 | ??14 | ????15 | ????15 | ????5 | ????15 | ????9 |
| Endothelium Corneum Gigeriae Galli | ????2.7 | ???3 | ???2 | ????3 | ????2.5 | ????3 | ????1 | ????3 |
| Fructus Gardeniae | ????1.3 | ?0.5 | ?1.5 | ????1 | ????1.5 | ???1.5 | ????1.5 | ???1.5 |
| Radix Panacis Quinquefolii | ????6.5 | ????8 | ?7.5 | ????8 | ????7 | ????7 | ????2 | ????8 |
| Cordyceps | ????2.6 | ????3 | ????2 | ????1 | ????3 | ????3 | ????3 | ????2 |
Method for production of the present invention: above-mentioned 1～No. 4 medicine screened respectively remove impurity, oven dry is ground into fine powder, crosses sieve No. 5, by the formulation weight mixing, packs in " 0 " number capsule, is finished product, every heavy 0.6g.
Capsular quality standard:
Moisture content: 90% ± 10%
Disintegration: 12 minutes standards: 30 minutes
Assorted bacterium: 198/g standard: 30-300/g
Escherichia coli: no standard: do not have individual/g
Acarid bacterium: no standard: do not have individual/g
Above-mentioned standard meets " one one of 95 years version of Chinese pharmacopoeia fully.
Instructions of taking of the present invention:
1-4 medicine of the present invention and Western medicine are used, and method is:
1, transfusion earlier defeated vitamin C 3-10 days, stops taking the present invention behind the liquid.
2, first No. 1 medicine of clothes, every day twice, each 2, take 5 days after, obey medicine 5-8 grain No. 2, take and take No. 1 medicine after 5 days again every day three times, every day twice, each 2, took 5 days, 15 days is a course of treatment altogether, takes No. 4 medicine every days 3 times then, each 2.Consolidate a course of treatment (7 days), the recidivist takes medicine 5-8 grain No. 3, and every day 3 times, each 2,7 days is a course of treatment.
Three groups of therapeutic effect statistical tables
| Grouping | Total routine number | Cure | The basic healing | Produce effects | Take a turn for the better | Sum | |||||
| The example number | ％ | The example number | ％ | The example number | ％ | The example number | ％ | The example number | ％ | ||
| The treatment group | 30 | ?29 | 97 | ?1 | ?3 | ||||||
| Matched group | 30 | ?15 | ?50 | ?9 | ?30 | ?4 | ?13.3 | ?1 | ?3.3 | ||
| Matched group | 30 | ?30 | 100 | ||||||||
Use the t inspection statistics and handle the evaluation cure rate as seen, the treatment group is apparently higher than matched group 1, and also apparently higher than matched group 2, P＜0.01 has significant difference.Cure with two groups of basic healings variant.t=4.63,0.01＜0.05。
Oral 1-4 medicine curative day statistical table of the present invention
| Grouping | Total routine number | 5 days | 10 days | 15 days | 30 days | 45 days | 60 days | ||||||
| The example number | ％ | The example number | ％ | The example number | ％ | The example number | ％ | The example number | ％ | The example number | ％ | ||
| The treatment group | 30 | ?1 | ?3.3 | ?3 | ?10 | ?24 | ?8 | ?2 | ?6.7 | ||||
| Matched group | 24 | ?4 | ?16.7 | ?15 | ?62.5 | ?4 | ?16.7 | ?1 | ?14.1 | ||||
Prove for taking patient's laboratory examination of the present invention: the present invention is to patient's routine blood test, platelet and go out clotting time, liver, renal function and have no effect, basically find no untoward reaction, only have the patient of 0.5-2% that slight abdominal discomfort and oral ulcer are arranged.
Bent type case:
Case 1: grandson so-and-so, man, 38 years old, Tangshan Vegetable Company workman.Before 10 years, do not have obvious inducement, two knee joints, duplex occur playing scurf after the erythema, and repeatedly treatment and oral a large amount of bimolane are invalid, after go Tianjin treatment, cures after one month and recurs again.Before January, psoriasis is multiple, involves whole body, is fused into sheet, and the inventor gives its defeated VC10 days earlier, and clothes the present invention 1, No. 2 medicines in back are cured 1 half course of treatment, and have taken medicine 3, No. 4, the pigmentation complete obiteration of leaving in the past, and it is normal that the colour of skin is recovered, so far not recurrence.
Case 2: the king so-and-so, the male, 50 years old, the Guye District people of Tangshan City, before 40 years, unknown cause plays little erythema from the head, after involve whole body, repeatedly fail to respond to any medical treatment, this institute adopts simple oral series Chinese medicine 1-4 number, not recurrence in 8 months is followed up a case by regular visits in three recoveries from illness courses of treatment.
Case 3: Zhang, man, 28 years old, people from Tangshan City.
Before 13 years, after cat fever, whole body plays point erythema and scurf, repeatedly treatment, and all not thorough, the Dong Kuang that comes January seeks medical advice, its transfusion vitamin C 3 days of originally doing, the oral 1-4 medicine of the present invention in back, the recovery from illness course of treatment.
Claims (6)
1, a kind of psoriasis capsule, it is made of four kinds of prescriptions, it is characterized in that:
A, prescription 1 are made up of six kinds of Chinese medicines, and the weight percent content of each medicine of distinguishing the flavor of is Calculus Bovis 1-5, Margarita 5-20, and favus skin 6-30 insults the colored 10-30 of the tip, Radix Tripterygii Wilfordii 6-20, Flos Sophorae 9-20;
B, prescription 2 are made of eight kinds of Chinese medicines, and the weight percent content of each medicine of distinguishing the flavor of is Herba Saussureae Involueratae 10-20, Margarita 10-20, Gypsum Fibrosum 10-20, Zaocys 8-18, Fructus Aurantii 5-15, Indigo Naturalis 5-15, Radix Angelicae Dahuricae 5-15, Fructus Arctii 5-15.
C, prescription 3 are made of 11 kinds of Chinese medicines, and the weight percent content of each medicine of distinguishing the flavor of is Os Draconis 8-20, Concha Ostreae 7-20, Semen Cassiae 10-30 not, Indigo Naturalis 5-15, Spica Prunellae 8-20, Pericarpium Citri Reticulatae Viride 5-20, Fructus Aurantii 5-15, Radix Scrophulariae 10-30, Radix Stemonae 3-15, Margarita 8-20, Radix Rumicis silk 1-5;
D, prescription 4 are made of 22 kinds of Chinese medicines, and the weight percent content of each medicine of distinguishing the flavor of is Radix Rehmanniae 3-13, Radix Glycyrrhizae 2-5, Hemerocallis citrina Baroni 5-15, Radix Angelicae Sinensis 4-8, Olibanum 0.5-3, Myrrha 0.5-2, Rhizoma Chuanxiong 0.5-1.5, Carapax et Plastrum Testudinis 1-4, Colla Corii Asini 1-3, Fructus Aurantii 1.5-5, each 1-3 of two skins, Rhizoma Pinelliae 0.5-3, Radix Platycodonis 0.5-1.5, Radix Bupleuri 0.5-2.5, Os Draconis 3-9, Concha Ostreae 2-6, Massa Medicata Fermentata 1-5, Fructus Hordei Germinatus 5-15, Endothelium Corneum Gigeriae Galli 1-3, Fructus Gardeniae 0.5-1.5, Radix Panacis Quinquefolii 2-8, Cordyceps 1-3.
2, psoriasis capsule according to claim 1, the optimized percentage content that it is characterized in that described prescription 1 is Calculus Bovis 3.6, Margarita 18.2, favus skin 16.3 is insulted the tip and is spent 27.3, Radix Tripterygii Wilfordii 16.4, Flos Sophorae 18.2.
3, psoriasis capsule according to claim 1, the optimized percentage content that it is characterized in that described prescription 2 is Herba Saussureae Involueratae 15, Margarita 15, Gypsum Fibrosum 15, Zaocys 15, Fructus Aurantii 10, Indigo Naturalis 10, the Radix Angelicae Dahuricae 10, Fructus Arctii 10.
4, psoriasis capsule according to claim 1, the optimized percentage content that it is characterized in that described prescription 3 is Os Draconis 9.3, Concha Ostreae 9.3, Semen Cassiae 15.4, Indigo Naturalis 9.3, Spica Prunellae 12.3, Pericarpium Citri Reticulatae Viride 9.3, Fructus Aurantii 6.2, Radix Scrophulariae 12.2, the Radix Stemonae 6.2, Margarita 9.3 Radix Rumicis silks 1.2.
5, psoriasis capsule according to claim 1, the optimized percentage content that it is characterized in that described prescription 4 is the Radix Rehmanniae 10.3, Radix Glycyrrhizae 3.2, the Radix Astragali 13.9, Radix Angelicae Sinensis 7.7, Olibanum 1.9, Myrrha 1.9, Rhizoma Chuanxiong 1.3, Carapax et Plastrum Testudinis 3.9, Colla Corii Asini 2.6, Fructus Aurantii 3.2, two skins each 1.9, the Rhizoma Pinelliae 1.9, Radix Platycodonis 1.3, Radix Bupleuri 1.9, Os Draconis 7.7, Concha Ostreae 5.2, Massa Medicata Fermentata 3.2, Fructus Hordei Germinatus 13.9, Endothelium Corneum Gigeriae Galli 2.7, Fructus Gardeniae 1.3, Radix Panacis Quinquefolii 6.5, Cordyceps 2.6.
6, psoriasis capsule according to claim 1 is characterized in that above-mentioned prescription is ground into respectively and does not make capsule, and the heavy 0.6g of every ball takes in proper order by prescription.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98100151A CN1058631C (en) | 1998-01-22 | 1998-01-22 | Psoriasis capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98100151A CN1058631C (en) | 1998-01-22 | 1998-01-22 | Psoriasis capsule |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1223870A true CN1223870A (en) | 1999-07-28 |
| CN1058631C CN1058631C (en) | 2000-11-22 |
Family
ID=5215838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN98100151A Expired - Fee Related CN1058631C (en) | 1998-01-22 | 1998-01-22 | Psoriasis capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1058631C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102784296A (en) * | 2012-08-19 | 2012-11-21 | 徐海波 | Fructus trichosanthis oral liquid |
| CN102805835A (en) * | 2012-09-06 | 2012-12-05 | 韩秀芳 | Method for treating psoriasis by traditional Chinese medicine |
| CN103893632A (en) * | 2014-04-16 | 2014-07-02 | 武海明 | Traditional Chinese medicine composition for treating psoriasis |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1080865A (en) * | 1993-01-05 | 1994-01-19 | 梁建奇 | Dermopathic Chinese medicine of a kind of treatment and preparation method |
| CN1128668A (en) * | 1995-11-08 | 1996-08-14 | 江苏苏晋集团公司 | Natural medicinal health-care products-complex prescription of pearl and snake powder |
| CN1052901C (en) * | 1996-02-09 | 2000-05-31 | 樊丽霞 | A Chinese medicinal pill for treating psoriasis and its preparation method |
| CN1165671A (en) * | 1996-05-21 | 1997-11-26 | 李玉英 | Method for prepn. of Chinese medicinal cream for treating psoriasis |
-
1998
- 1998-01-22 CN CN98100151A patent/CN1058631C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102784296A (en) * | 2012-08-19 | 2012-11-21 | 徐海波 | Fructus trichosanthis oral liquid |
| CN102805835A (en) * | 2012-09-06 | 2012-12-05 | 韩秀芳 | Method for treating psoriasis by traditional Chinese medicine |
| CN103893632A (en) * | 2014-04-16 | 2014-07-02 | 武海明 | Traditional Chinese medicine composition for treating psoriasis |
| CN103893632B (en) * | 2014-04-16 | 2016-04-13 | 武海明 | One treats psoriasic Chinese medicine composition |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1058631C (en) | 2000-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1095610A (en) | The pharmaceutical preparation Fubingkang of treatment, prevention gynecological diseases | |
| CN1562160A (en) | Composite medicine for treating hepatitis B complication | |
| CN104587442A (en) | Foot bath traditional Chinese medicine composition for treating wind-cold-dampness arthralgia and application of foot bath traditional Chinese medicine composition | |
| CN1876053A (en) | A pharmaceutical used for moxibustion and preparation method thereof | |
| CN1351872A (en) | Chinese herbal medicine for curing comedo and acne | |
| CN1223870A (en) | Psoriasis capsule | |
| CN1076619C (en) | Moxiburning medicine for acupoint therapy | |
| CN1063650C (en) | Chinese medicinal pill for curing rheumatism and rheumatoid disease and its preparation method | |
| CN102416117A (en) | Chinese patent medicine for treating psoriasis | |
| CN1557445A (en) | Chinese patent medicine for treating cervical spondylosis | |
| CN105688059A (en) | Traditional Chinese medicine preparation with folium artemisiae argyi for treating osteoproliferation through external application | |
| CN1158091C (en) | Chinese medicine composition for treating lung cancer | |
| CN1200724C (en) | Pill for activating collateral flow and removing spur | |
| CN1059117C (en) | Katsutoxin pill for tumor and preparing method thereof | |
| CN1720938A (en) | Medicine for treating rheumatic arthritis and ankylosing spondylitis and its preparing process | |
| CN1055241C (en) | Medicine for pulmonary tuberculosis and its preparation method | |
| CN116350731B (en) | Formula for clearing heat, removing dampness and relieving arthralgia as well as preparation and application thereof | |
| CN1241580C (en) | Medicinal composition for treating hypersteogeny | |
| CN1201811C (en) | Chinese medicine composition for treating myopia and preparing method thereof | |
| CN1204911C (en) | Orally taken Chinese medicine for treating endocrine dyscrasia | |
| CN1330360C (en) | Chinese traditional medicine for treating rheumatoid disease | |
| CN104971209A (en) | Externally used agent for treating tinea pedis and preparation method thereof | |
| CN104524157B (en) | A kind of Chinese medicine preparation for the treatment of goiter | |
| CN1068523C (en) | Medicine for treating cancer and its preparing technology | |
| CN116870072A (en) | Traditional Chinese medicine composition, application, gel and preparation method of gel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |